Professor Jennifer Martin (FRACP, PhD) is a dual-accredited clinical pharmacologist and physician, and holds an MA in politics and economics from Oxford University. Her basic science PhD is from Monash University, following which she held a postdoctoral fellowship at the Walter and Eliza Hall Institute.

Jennifer has held clinical and research posts in clinical pharmacology since 2000 and has had over 15 years of experience on national (both Australian and New Zealand) state and local bodies in the area of pharmacovigilance, pharmacoeconomics, pharmaceutical pricing and regulation. She has worked for Bristol Myers Squibb in the pharmacoeconomic and regulatory departments, and in medical departments in the cardiovascular therapeutic area.

In 2014, Jennifer left her role as Head of one of the largest clinical training facilities in Australasia, responsible for the training and medical performance of 600 medical students and ensuring access to research training programs, facilities and posts in the clinical school, to take a Chair of Clinical Pharmacology and Head of Medicine at the University of Newcastle.

Her research spans all of the pharmacology disciplines from basic to translational, which is pivotal for the success of ACRE to in filling the gaps in research and translation in medicinal cannabinoids. Although she has over 100 publications in the pharmacology area, her recent research focus has moved to the translational and clinical practice areas, with roles on clinical and prescribing guidelines, recommendations and roles in national and international regulatory and pricing bodies and policy committees (e.g. the College of Physicians, National Prescribing Service and NSW Health), latterly in cannabinoid policy.

These leadership and governance roles in pharmacology enhance the certainty of ACRE’s cannabinoid research being effectively translated into practice, and of ensuring research capacity continues to build and deliver long-term.